South Carolina § 44-137-70 Insurance coverage; costs; services.

South Carolina Statutes

§ 44-137-70 — Insurance coverage; costs; services.

South Carolina § 44-137-70

Title 44HEALTH

Ch. 137RIGHT TO TRY ACT

This text of South Carolina § 44-137-70 (Insurance coverage; costs; services.) is published on Counsel Stack Legal Research, covering South Carolina primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

S.C. Code Ann. § 44-137-70 (2026).

Text

(A)This chapter does not expand coverage an insurer must provide pursuant to Title 38.

(B)This chapter does not require:

(1)a governmental agency to pay costs associated with the use, care, or treatment of a patient with an investigational drug, biological product, or device; or (2) a hospital or other health care facility licensed pursuant to Chapter 7, Title 44 to provide new or additional services, unless approved or required by the hospital or facility.

(C)A health plan, third party administrator, or governmental agency is not required to, but may, provide coverage for the cost of an investigational drug, biological product, or device, or the cost of services related to the use of an investigational drug, biological product, or device under this chapter.

Free access — add to your briefcase to read the full text and ask questions with AI

(A) This chapter does not expand coverage an insurer must provide pursuant to Title 38. (B) This chapter does not require: (1) a governmental agency to pay costs associated with the use, care, or treatment of a patient with an investigational drug, biological product, or device; or (2) a hospital or other health care facility licensed pursuant to Chapter 7, Title 44 to provide new or additional services, unless approved or required by the hospital or facility. (C) A health plan, third party administrator, or governmental agency is not required to, but may, provide coverage for the cost of an investigational drug, biological product, or device, or the cost of services related to the use of an investigational drug, biological product, or device under this chapter.